Dialysis News and Research

Latest Dialysis News and Research

U.S. Renal Care, DSI Renal sign definitive merger agreement

U.S. Renal Care, DSI Renal sign definitive merger agreement

WHO provides emergency health access to internally displaced persons, host communities in Taiz and Hodeida governorates

WHO provides emergency health access to internally displaced persons, host communities in Taiz and Hodeida governorates

Wyss Institute scientists develop improved blood-cleansing therapeutic device to treat sepsis

Wyss Institute scientists develop improved blood-cleansing therapeutic device to treat sepsis

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

EMPA-REG OUTCOME trial demonstrates superiority of Jardiance in T2D patients at risk for CV events

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

Omeros reports additional positive data from OMS721 Phase 2 trial for treatment of thrombotic microangiopathies

DaVita HealthCare Partners hosts health and disaster preparedness fair in Colorado Springs

DaVita HealthCare Partners hosts health and disaster preparedness fair in Colorado Springs

Quanta receives i4i award from NIHR to develop new product concept for nocturnal haemodialysis

Quanta receives i4i award from NIHR to develop new product concept for nocturnal haemodialysis

NxStage System One now used in eight of Top 10 Nephrology Hospitals in the U.S.

NxStage System One now used in eight of Top 10 Nephrology Hospitals in the U.S.

Ardelyx reports net income of $9.0 million for second quarter 2015

Ardelyx reports net income of $9.0 million for second quarter 2015

Only 1 in 4 patients with ESRD in Georgia referred for kidney transplant evaluation

Only 1 in 4 patients with ESRD in Georgia referred for kidney transplant evaluation

LA BioMed researcher launches study to examine medication adherence among patients with dialysis

LA BioMed researcher launches study to examine medication adherence among patients with dialysis

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

UChicago Medicine contributes to Illinois Transplant Fund

UChicago Medicine contributes to Illinois Transplant Fund

Finding by UCSF researchers could increase availability of kidneys for transplant

Finding by UCSF researchers could increase availability of kidneys for transplant

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

NEJM suggests use of HCV-positive kidneys as one solution to kidney shortage

3SBio purchases entire equity interest in Zhejiang Wansheng

3SBio purchases entire equity interest in Zhejiang Wansheng

UC San Diego researchers identify pivotal player in diabetic kidney disease

UC San Diego researchers identify pivotal player in diabetic kidney disease

Tyrone Regional Health Network signs letter of intent to become member of Penn State Health

Tyrone Regional Health Network signs letter of intent to become member of Penn State Health

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

New drug patiromer could improve potassium levels of patients with diabetic kidney disease

HealthCare Partners California division honored with Elite Status by CAPG

HealthCare Partners California division honored with Elite Status by CAPG

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.